These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 25896424)
1. Inhibition of STAT3 signaling as critical molecular event in resveratrol-suppressed ovarian cancer cells. Zhong LX; Li H; Wu ML; Liu XY; Zhong MJ; Chen XY; Liu J; Zhang Y J Ovarian Res; 2015 Apr; 8():25. PubMed ID: 25896424 [TBL] [Abstract][Full Text] [Related]
2. Correlation of ARHI upregulation with growth suppression and STAT3 inactivation in resveratrol-treated ovarian cancer cells. Zhong LX; Nie JH; Liu J; Lin LZ Cancer Biomark; 2018; 21(4):787-795. PubMed ID: 29504523 [TBL] [Abstract][Full Text] [Related]
3. Biological significance and therapeutic implication of resveratrol-inhibited Wnt, Notch and STAT3 signaling in cervical cancer cells. Zhang P; Li H; Yang B; Yang F; Zhang LL; Kong QY; Chen XY; Wu ML; Liu J Genes Cancer; 2014 May; 5(5-6):154-64. PubMed ID: 25061499 [TBL] [Abstract][Full Text] [Related]
4. PIAS3, SHP2 and SOCS3 Expression patterns in Cervical Cancers: Relevance with activation and resveratrol-caused inactivation of STAT3 signaling. Zhang P; Yang B; Yao YY; Zhong LX; Chen XY; Kong QY; Wu ML; Li C; Li H; Liu J Gynecol Oncol; 2015 Dec; 139(3):529-35. PubMed ID: 26432044 [TBL] [Abstract][Full Text] [Related]
5. Resveratrol suppresses the STAT3 signaling pathway and inhibits proliferation of high glucose-exposed HepG2 cells partly through SIRT1. Li Y; Zhu W; Li J; Liu M; Wei M Oncol Rep; 2013 Dec; 30(6):2820-8. PubMed ID: 24064760 [TBL] [Abstract][Full Text] [Related]
6. SHP2, SOCS3 and PIAS3 Expression Patterns in Medulloblastomas: Relevance to STAT3 Activation and Resveratrol-Suppressed STAT3 Signaling. Li C; Li H; Zhang P; Yu LJ; Huang TM; Song X; Kong QY; Dong JL; Li PN; Liu J Nutrients; 2016 Dec; 9(1):. PubMed ID: 28035977 [TBL] [Abstract][Full Text] [Related]
7. Pterostilbene exerts antitumor activity against human osteosarcoma cells by inhibiting the JAK2/STAT3 signaling pathway. Liu Y; Wang L; Wu Y; Lv C; Li X; Cao X; Yang M; Feng D; Luo Z Toxicology; 2013 Feb; 304():120-31. PubMed ID: 23313376 [TBL] [Abstract][Full Text] [Related]
8. STAT3 signaling statuses determine the fate of resveratrol-treated anaplastic thyroid cancer cells. Wu J; Li YT; Tian XT; Liu YS; Wu ML; Li PN; Liu J Cancer Biomark; 2020; 27(4):461-469. PubMed ID: 31958078 [TBL] [Abstract][Full Text] [Related]
9. Resveratrol and STAT inhibitor enhance autophagy in ovarian cancer cells. Zhong LX; Zhang Y; Wu ML; Liu YN; Zhang P; Chen XY; Kong QY; Liu J; Li H Cell Death Discov; 2016; 2():15071. PubMed ID: 27551495 [TBL] [Abstract][Full Text] [Related]
10. Pterostilbene Suppresses Ovarian Cancer Growth via Induction of Apoptosis and Blockade of Cell Cycle Progression Involving Inhibition of the STAT3 Pathway. Wen W; Lowe G; Roberts CM; Finlay J; Han ES; Glackin CA; Dellinger TH Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986501 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of STAT3 expression and signaling in resveratrol-differentiated medulloblastoma cells. Yu LJ; Wu ML; Li H; Chen XY; Wang Q; Sun Y; Kong QY; Liu J Neoplasia; 2008 Jul; 10(7):736-44. PubMed ID: 18592012 [TBL] [Abstract][Full Text] [Related]
12. GRIM‑19‑mediated Stat3 activation is a determinant for resveratrol‑induced proliferation and cytotoxicity in cervical tumor‑derived cell lines. Li YG; Xia HJ; Tao JP; Xin P; Liu MY; Li JB; Zhu W; Wei M Mol Med Rep; 2015 Feb; 11(2):1272-7. PubMed ID: 25351437 [TBL] [Abstract][Full Text] [Related]
13. Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer. Wen W; Wu J; Liu L; Tian Y; Buettner R; Hsieh MY; Horne D; Dellinger TH; Han ES; Jove R; Yim JH Mol Cancer; 2015 May; 14():100. PubMed ID: 25928246 [TBL] [Abstract][Full Text] [Related]
14. Discovery of oral-available resveratrol-caffeic acid based hybrids inhibiting acetylated and phosphorylated STAT3 protein. Li S; Zhang W; Yang Y; Ma T; Guo J; Wang S; Yu W; Kong L Eur J Med Chem; 2016 Nov; 124():1006-1018. PubMed ID: 27783972 [TBL] [Abstract][Full Text] [Related]
15. ESC-3 induces apoptosis of human ovarian carcinomas through Wnt/β-catenin and Notch signaling in vitro and in vivo. Fu QR; Song W; Deng YT; Li HL; Mao XM; Lin CL; Zheng YH; Chen SM; Chen QH; Chen QX Int J Oncol; 2017 Jan; 50(1):241-251. PubMed ID: 27878242 [TBL] [Abstract][Full Text] [Related]
16. Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer. Duan Z; Foster R; Bell DA; Mahoney J; Wolak K; Vaidya A; Hampel C; Lee H; Seiden MV Clin Cancer Res; 2006 Sep; 12(17):5055-63. PubMed ID: 16951221 [TBL] [Abstract][Full Text] [Related]
17. The STAT3-miRNA-92-Wnt Signaling Pathway Regulates Spheroid Formation and Malignant Progression in Ovarian Cancer. Chen MW; Yang ST; Chien MH; Hua KT; Wu CJ; Hsiao SM; Lin H; Hsiao M; Su JL; Wei LH Cancer Res; 2017 Apr; 77(8):1955-1967. PubMed ID: 28209618 [TBL] [Abstract][Full Text] [Related]